• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Greenhill Brands Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday

    11/4/22 4:41:19 AM ET
    $AFIB
    $AHG
    $APM
    $APTO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Real Estate
    Real Estate
    Get the next $AFIB alert in real time by email

    Gainers

    • Huadi International Group Co., Ltd. (NASDAQ:HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
    • Acutus Medical, Inc. (NASDAQ:AFIB) gained 39.7% to close at $0.9781. Acutus Medical achieved OEM qualification milestone in sale of left-heart access portfolio to Medtronic.
    • NerdWallet, Inc. (NASDAQ:NRDS) shares jumped 37.4% to close at $13.63 after the company reported better-than-expected Q3 EPS and sales results.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) gained 36.3% to settle at $2.29 after the company announced the distribution of a RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit has been launched in markets accepting the CE mark, such as the European Union.
    • Avalon GloboCare Corp. (NASDAQ:AVCO) jumped 34.8% to settle at $0.5149.
    • Aptose Biosciences Inc. (NASDAQ:APTO) climbed 26.9% to close at $0.7180.
    • Provention Bio, Inc. (NASDAQ:PRVB) shares climbed 26.1% to close at $8.41 after reporting a narrower-than-expected Q3 loss.
    • Greenhill & Co., Inc. (NYSE:GHL) climbed 24.6% to close at $9.12 after the company reported better-than-expected Q3 sales results.
    • Cardlytics, Inc. (NASDAQ:CDLX) jumped 24.6% to close at $5.62. Cardlytics recently reported worse-than-expected Q3 sales.
    • Aptorum Group Limited (NASDAQ:APM) gained 24.2% to settle at $0.7908.
    • Sentage Holdings Inc. (NASDAQ:SNTG) gained 24.1% to close at $3.04.
    • Veracyte, Inc. (NASDAQ:VCYT) climbed 24.3% to close at $24.23 after the company reported better-than-expected Q3 EPS and sales results. The company also raised its FY22 sales gudiance above analyst estimates.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) gained 24.1% to close at $0.50. Creative Medical Technology announced FDA clearance of investigational new drug application for AlloStem.
    • VOC Energy Trust (NYSE:VOC) gained 23.8% to close at $9.82.
    • Galecto, Inc. (NASDAQ:GLTO) jumped 23.2% to settle at $2.34.
    • Bluegreen Vacations Holding Corporation (NYSE:BVH) climbed 22.7% to close at $20.92 folloiwng better-than-expected Q3 earnings. Bluegreen Vacations announced intention to commence a cash tender offer for its class A common stock at $22.17 per share.
    • Aravive, Inc. (NASDAQ:ARAV) gained 21.5% to settle at $2.09.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) rose 19.7% to close at $2.37.
    • Axsome Therapeutics, Inc. (NASDAQ:AXSM) jumped 19.6% to close at $60.39.
    • Infinera Corporation (NASDAQ:INFN) climbed 19.5% to settle at $6.25 after the company reported better-than-expected Q3 EPS and sales results..
    • Sunrun Inc. (NASDAQ:RUN) rose 18.7% to close at $25.71 after the company reported better-than-expected Q3 results.
    • Ecoark Holdings, Inc. (NASDAQ:ZEST) gained 18.7% to settle at $1.05.
    • Tecnoglass Inc. (NYSE:TGLS) jumped 18.7% to close at $23.63 as the company posted upbeat Q3 results and announced a $50 million buyback program.
    • American Axle & Manufacturing Holdings, Inc. (NYSE:AXL) gained 18.6% to close at $10.80. American Axle is said to also gauge interest from Borgwarner, Dana.
    • 10x Genomics, Inc. (NASDAQ:TXG) gained 18.5% to close at $31.90 after the company reported better-than-expected Q3 EPS and sales results.
    • Valens Semiconductor Ltd. (NYSE:VLN) jumped 18.4% to settle at $3.99.
    • Vimeo, Inc. (NASDAQ:VMEO) gained 17.1% to close at $3.91 after the company reported better-than-expected Q3 EPS and sales results.
    • Frontdoor, Inc. (NASDAQ:FTDR) jumped 16.8% to settle at $24.16 after the company reported better-than-expected Q3 results and issued Q4 and FY22 revenue guidance.
    • 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) climbed 16.6% to close at $8.15 following upbeat quarterly results.
    • Tile Shop Holdings, Inc. (NASDAQ:TTSH) climbed 15.7% to close at $4.35 after the company reported better-than-expected Q3 EPS results.
    • e.l.f. Beauty, Inc. (NYSE:ELF) gained 15.4% to close at $48.09 after the company reported better-than-expected Q2 EPS and sales results and raised FY23 adjusted EPS and sales guidance above analyst estimates.
    • MBIA Inc. (NYSE:MBI) jumped 15.3% to close at $11.51 following Q3 earnings.
    • Distribution Solutions Group, Inc. (NASDAQ:DSGR) rose 15.3% to close at $34.48 after the company posted upbeat Q3 results and increased share repurchase plan to $12.5 million.
    • Mesa Laboratories, Inc. (NASDAQ:MLAB) jumped 15.3% to settle at $147.54 following Q2 results.
    • StoneCo Ltd. (NASDAQ:STNE) gained 14.8% to close at $12.04.
    • Etsy, Inc. (NASDAQ:ETSY) rose 14.3% to close at $100.03 after the company reported better-than-expected Q3 sales results.
    • Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) climbed 13.5% to close at $10.58. William Blair upgraded Lindblad Expeditions from Market Perform to Outperform.
    • Lancaster Colony Corporation (NASDAQ:LANC) climbed 11% to close at $195.89 following upbeat quarterly earnings.
    • Under Armour, Inc. (NYSE:UA) gained 10.6% to close at $6.91 after the company reported better-than-expected Q3 EPS and sales results.
    • Digital Brands Group, Inc. (NASDAQ:DBGI) climbed 10.9% to close at $0.0812 after jumping 10% on Wednesday. Digital Brands recently said its new multi-brand website has seen a 462% increase in e-commerce revenue since its launch on October 23, 2022.
    • Zillow Group, Inc. (NASDAQ:Z) gained 10.4% to close at $32.61 following strong quarterly sales.
    • Bit Origin Ltd (NASDAQ:BTOG) gained 8.8% to close at $0.2301.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) gained 8.2% to close at $12.33 after reporting upbeat Q3 results.
    • ING Groep N.V. (NYSE:ING) rose 8.2% to settle at $10.43 after the company reported Q3 results and announced a share buyback programme of up to €1.5 billion.
    • HubSpot, Inc. (NYSE:HUBS) gained 5.7% to close at $278.56 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 EPS and FY22 EPS and sales guidance above analyst estimates.

     

    Losers

    • Ignyte Acquisition Corp. (NASDAQ:PKBO) fell 45.6% to close at $3.80 on Thursday.
    • Vapotherm, Inc. (NYSE:VAPO) shares fell 40.3% to close at $1.26 on Thursday after the company reported worse-than-expected Q3 results.
    • Surgalign Holdings, Inc. (NASDAQ:SRGA) dipped 34.4% to close at $2.00 after the company reported worse-than-expected Q3 sales results and lowered its FY22 sales guidance below analyst estimates.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) fell 33.3% to settle at $4.67.
    • Lincoln National Corporation (NYSE:LNC) dropped 33.2% to close at $34.83 after the company reported worse-than-expected Q3 EPS results.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) declined 32.3% to settle at $0.3150.
    • Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) fell 31.9% to close at $5.18. Aurinia Pharmaceuticals posted a Q3 loss of $0.06 per share.
    • Satixfy Communications Ltd. (NYSE:SATX) declined 31.1% to close at $7.67.
    • First High-School Education Group Co., Ltd. (NYSE:FHS) dropped 30.5% to settle at $0.23.
    • Altice USA, Inc. (NYSE:ATUS) fell 29.1% to close at $4.44 after the company reported worse-than-expected Q3 results.
    • Selina Hospitality PLC (NASDAQ:SLNA) dipped 28.6% to settle at $4.4999.
    • Tandem Diabetes Care, Inc. (NASDAQ:TNDM) declined 28.4% to close at $36.77 after the company reported worse-than-expected Q3 sales results.
    • Fidelity National Information Services, Inc. (NYSE:FIS) fell 28.1% to close at $57.18 after the company reported worse-than-expected Q3 EPS and sales results. The company also issued Q4 and FY22 EPS and sales guidance below analyst estimates.
    • Energy Recovery, Inc. (NASDAQ:ERII) dropped 27.5% to close at $18.29 following weak quarterly sales.
    • CURO Group Holdings Corp. (NYSE:CURO) dropped 26.1% to close at $3.66 after the company reported Q3 EPS results down from last year and worse-than-expected sales results.
    • CommScope Holding Company, Inc. (NASDAQ:COMM) declined 26% to close at $9.53 following Q3 results.
    • Merus N.V. (NASDAQ:MRUS) dropped 25% to close at $15.28 after the FDA recommended the company enroll additional patients in the eNRGy trial to support potential BLA filing.
    • Advanced Drainage Systems, Inc. (NYSE:WMS) dipped 25% to close at $85.07 following weak quarterly results.
    • Identiv, Inc. (NASDAQ:INVE) declined 24.8% to close at $8.83 after the company reported worse-than-expected Q3 results and issued soft FY22 guidance.
    • Palomar Holdings, Inc. (NASDAQ:PLMR) declined 24.5% to close at $64.41 following downbeat quarterly earnings.
    • Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) fell 24.5% to settle at $3.6250.
    • Yellow Corporation (NASDAQ:YELL) dropped 24.3% to settle at $3.09 after the company reported Q3 EPS results down from last year and worse-than-expected sales results.
    • Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) fell 23.8% to close at $2.05.
    • Orbital Infrastructure Group, Inc.. (NASDAQ:OIG) fell 23.4% to close at $0.2876 after the company cut its FY22 forecast.
    • Ryerson Holding Corporation (NYSE:RYI) fell 22.8% to close at $24.42 following downbeat quarterly earnings.
    • Inseego Corp. (NASDAQ:INSG) dropped 22.8% to close at $1.69 after the company reported worse-than-expected Q3 EPS results.
    • Rapid7, Inc. (NASDAQ:RPD) fell 22.7% to close at $30.19 after the company reported Q3 earnings results.
    • Freight Technologies, Inc. (NASDAQ:FRGT) dipped 21.9% to close at $0.25.
    • Intrepid Potash, Inc. (NYSE:IPI) dropped 20.5% to close at $34.24 after the company reported worse-than-expected Q3 results.
    • Nogin, Inc. (NASDAQ:NOGN) dipped 20.4% to settle at $0.67.
    • Rimini Street, Inc. (NASDAQ:RMNI) fell 20.4% to close at $4.33 after the company reported worse-than-expected Q3 sales and issued soft FY22 guidance.
    • Tenax Therapeutics, Inc. (NASDAQ:TENX) dipped 20% to close at $0.1082.
    • Lightspeed Commerce Inc. (NYSE:LSPD) fell 18.6% to settle at $14.61 following Q2 results.
    • Pediatrix Medical Group, Inc. (NYSE:MD) declined 18.5% to close at $15.18 following Q3 results.
    • Butterfly Network, Inc. (NASDAQ:BFLY) dipped 17.8% to settle at $3.94 following Q3 resulst.
    • Lumen Technologies, Inc. (NYSE:LUMN) shares fell 17.7% to close at $5.80 after the company reported worse-than-expected Q3 results. The company also entered into agreement regarding divestiture of EMEA business to Colt Technology Services for $1.8 billion.
    • WideOpenWest, Inc. (NYSE:WOW) fell 16.4% to close at $11.20 after the company posted downbeat quarterly results and lowered FY22 revenue outlook.
    • TuSimple Holdings Inc. (NASDAQ:TSP) dropped 16.2% to settle at $2.85.
    • Qualys, Inc. (NASDAQ:QLYS) dropped 16% to close at $112.38 after the company reported Q3 earnings results.
    • Verra Mobility Corporation (NASDAQ:VRRM) fell 15.6% to settle at $13.62 following Q3 results.
    • STAAR Surgical Company (NASDAQ:STAA) dropped 15.3% to settle at $59.84 after reporting Q3 results.
    • WESCO International, Inc. (NYSE:WCC) dipped 15.2% to close at $116.47 after the company reported mixed Q3 results and issued FY22 EPS guidance with a midpoint below estimates.
    • Quotient Limited (NASDAQ:QTNT) fell 15% to close at $2.16. Quotient announced a 1-for-40 reverse stock split.
    • R1 RCM Inc. (NASDAQ:RCM) dropped 15% to close at $14.77.
    • Rogers Corporation (NYSE:ROG) fell 14.8% to settle at $108.89 after Dupont recently announced it is terminating its intended acquisition of the company.
    • Braemar Hotels & Resorts Inc. (NYSE:BHR) dropped 14% to close at $3.86 following Q3 results.
    • Cognizant Technology Solutions Corporation (NASDAQ:CTSH) fell 13.8% to close at $51.96 after the company reported downbeat quarterly sales.
    • Fortinet, Inc. (NASDAQ:FTNT) fell 13.7% to close at $45.93 following quarterly results.
    • Nu Skin Enterprises, Inc. (NYSE:NUS) dropped 13.4% to close at $31.79 following downbeat Q3 results.
    • Kyndryl Holdings, Inc. (NYSE:KD) dropped 12.5% to close at $8.45 following downbeat quarterly earnings.
    • Zoetis Inc. (NYSE:ZTS) dropped 11% to close at $131.14 after the company reported worse-than-expected Q3 EPS and sales results. The company also lowered its FY22 EPS guidance below analyst estimates.
    • Kellogg Company (NYSE:K) dropped 8.3% to close at $69.51 after the company reported Q3 financial results.
    • Palo Alto Networks, Inc. (NASDAQ:PANW) fell 7.5% to close at $149.70 in sympathy with Fortinet, which fell after the company reported Q3 financial results.
    • Akso Health Group (NASDAQ:AHG) fell 6.8% to close at $0.41 after declining around 13% on Wednesday.
    • Roku, Inc. (NASDAQ:ROKU) fell 4.6% to close at $51.84. Roku posted upbeat revenue for its third quarter, but issued weak forecast for the fourth quarter.
    Get the next $AFIB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFIB
    $AHG
    $APM
    $APTO

    CompanyDatePrice TargetRatingAnalyst
    Robinhood Markets Inc.
    $HOOD
    4/21/2026$120.00 → $110.00Overweight
    KeyBanc Capital Markets
    Palo Alto Networks Inc.
    $PANW
    4/21/2026$215.00Buy
    Berenberg
    Robinhood Markets Inc.
    $HOOD
    4/20/2026$105.00 → $115.00Outperform
    Mizuho
    Kyndryl Holdings Inc.
    $KD
    4/20/2026$15.00Market Perform
    BMO Capital Markets
    Zoetis Inc.
    $ZTS
    4/15/2026$145.00Buy
    Citigroup
    Energy Recovery Inc.
    $ERII
    4/15/2026Buy → Neutral
    Northcoast
    Veracyte Inc.
    $VCYT
    4/13/2026$45.00Buy
    Jefferies
    Cognizant Technology Solutions Corporation
    $CTSH
    4/9/2026$61.00Neutral
    Wedbush
    More analyst ratings

    $AFIB
    $AHG
    $APM
    $APTO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TZIELD issued to PROVENTION BIO INC

    Submission status for PROVENTION BIO INC's drug TZIELD (SUPPL-13) with active ingredient TEPLIZUMAB-MZWV has changed to 'Approval' on 04/20/2026. Application Category: BLA, Application Number: 761183, Application Classification:

    4/23/26 6:14:48 PM ET
    $PRVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 28, 2025 - FDA Roundup: February 28, 2025

    For Immediate Release: February 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA approved Odactra to include use in individuals 5 through 11 years of age to treat house dust mite induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis). Odactra is an allergen extract immunotherapy

    2/28/25 5:00:47 PM ET
    $TNDM
    Medical/Dental Instruments
    Health Care

    December 6, 2024 - FDA Roundup: December 6, 2024

    For Immediate Release: December 06, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:On Thursday, the FDA published the draft guidance, “Expedited Program for Serious Conditions — Accelerated Approval of Drugs and Biologics,” which proposes updates to certain agency policies and procedures regarding accelerated approval. Topics addressed by this

    12/6/24 3:09:02 PM ET
    $MRUS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFIB
    $AHG
    $APM
    $APTO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets reiterated coverage on Robinhood Markets with a new price target

    KeyBanc Capital Markets reiterated coverage of Robinhood Markets with a rating of Overweight and set a new price target of $110.00 from $120.00 previously

    4/21/26 9:33:04 AM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    Berenberg initiated coverage on Palo Alto Networks with a new price target

    Berenberg initiated coverage of Palo Alto Networks with a rating of Buy and set a new price target of $215.00

    4/21/26 7:33:51 AM ET
    $PANW
    Computer peripheral equipment
    Technology

    Mizuho reiterated coverage on Robinhood Markets with a new price target

    Mizuho reiterated coverage of Robinhood Markets with a rating of Outperform and set a new price target of $115.00 from $105.00 previously

    4/20/26 9:28:24 AM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    $AFIB
    $AHG
    $APM
    $APTO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by President and CEO Kadia Siddhartha

    4 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    4/24/26 10:49:12 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form 3 filed by new insider Kadia Siddhartha

    3 - MESA LABORATORIES INC /CO/ (0000724004) (Issuer)

    4/24/26 10:41:18 AM ET
    $MLAB
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Chief Operating Officer Jacobson Mark L.

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    4/23/26 9:02:45 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFIB
    $AHG
    $APM
    $APTO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Energy Holding Corp bought $9,727,810 worth of Ordinary Shares (215,229 units at $45.20), increasing direct ownership by 1% to 20,731,985 units (SEC Form 4)

    4 - Tecnoglass Inc. (0001534675) (Issuer)

    3/16/26 4:58:07 PM ET
    $TGLS
    Electronic Components
    Consumer Discretionary

    EVP, Chief Information Officer Charters Jennifer bought $9,783 worth of shares (300 units at $32.61), increasing direct ownership by 0.80% to 37,796 units (SEC Form 4)

    4 - LINCOLN NATIONAL CORP (0000059558) (Issuer)

    3/16/26 4:19:13 PM ET
    $LNC
    Life Insurance
    Finance

    Director Broadwood Partners, L.P. bought $12,266,545 worth of shares (670,213 units at $18.30) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    3/13/26 7:59:59 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    $AFIB
    $AHG
    $APM
    $APTO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Belcan Honored for Commitment to U.S. Navy Reservists

    CINCINNATI, April 24, 2026 /PRNewswire/ -- Belcan (a Cognizant company), a global supplier of design, software, manufacturing, supply chain, information technology, and digital engineering solutions to the aerospace, defense, space, automotive, industrial, marine, and government services markets, today announced that the U.S. Navy named Belcan Government Solutions (BGS) one of America's outstanding Navy Reserve employers for 2026 in recognition of its exceptional support of its reservists. "It is a profound honor for Belcan to be recognized by the U.S. Navy for our support of ou

    4/24/26 7:00:00 AM ET
    $CTSH
    EDP Services
    Technology

    StoneCo Files Its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025

    George Town, Grand Cayman--(Newsfile Corp. - April 23, 2026) - StoneCo Ltd. (NASDAQ:STNE) ("Stone" or "the Company") hereby informs its shareholders and the market that has filed today, April 23, its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC").The report is available on the SEC's website, at www.sec.gov, and on StoneCo's Investor Relations website, at https://investors.stone.co. About StoneCoStone Co. is a leading provider of financial technology solutions that empower merchants to conduct commerce seamlessly across multiple channels and help them grow their businesses with our payments, banking, and cre

    4/23/26 6:02:00 PM ET
    $STNE
    EDP Services
    Technology

    UNDER ARMOUR ANNOUNCES DATE FOR FOURTH QUARTER AND FULL-YEAR FISCAL 2026 EARNINGS CONFERENCE CALL

    BALTIMORE, April 23, 2026 /PRNewswire/ -- Under Armour, Inc. (NYSE:UA, UAA)) today announced that it will release its fourth quarter and full-year fiscal 2026 financial results, for the period ended March 31, 2026, on May 12, 2026. Following the earnings release, which will be issued at approximately 6:55 a.m. Eastern Time (ET), Under Armour management will host a conference call at approximately 8:30 a.m. ET to discuss the company's results.The conference call will be webcast live and available for replay on Under Armour's Investor Relations website at: https://about.underarmou

    4/23/26 4:30:00 PM ET
    $UA
    $UAA
    Apparel
    Consumer Discretionary

    $AFIB
    $AHG
    $APM
    $APTO
    SEC Filings

    View All

    SEC Form FWP filed by Lincoln National Corporation

    FWP - LINCOLN NATIONAL CORP (0000059558) (Subject)

    4/24/26 7:27:44 AM ET
    $LNC
    Life Insurance
    Finance

    SEC Form 6-K filed by ING Group N.V.

    6-K - ING GROEP NV (0001039765) (Filer)

    4/24/26 6:05:04 AM ET
    $ING
    Commercial Banks
    Finance

    SEC Form EFFECT filed by Sonoma Pharmaceuticals Inc.

    EFFECT - Sonoma Pharmaceuticals, Inc. (0001367083) (Filer)

    4/24/26 12:15:24 AM ET
    $SNOA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFIB
    $AHG
    $APM
    $APTO
    Financials

    Live finance-specific insights

    View All

    UNDER ARMOUR ANNOUNCES DATE FOR FOURTH QUARTER AND FULL-YEAR FISCAL 2026 EARNINGS CONFERENCE CALL

    BALTIMORE, April 23, 2026 /PRNewswire/ -- Under Armour, Inc. (NYSE:UA, UAA)) today announced that it will release its fourth quarter and full-year fiscal 2026 financial results, for the period ended March 31, 2026, on May 12, 2026. Following the earnings release, which will be issued at approximately 6:55 a.m. Eastern Time (ET), Under Armour management will host a conference call at approximately 8:30 a.m. ET to discuss the company's results.The conference call will be webcast live and available for replay on Under Armour's Investor Relations website at: https://about.underarmou

    4/23/26 4:30:00 PM ET
    $UA
    $UAA
    Apparel
    Consumer Discretionary

    FIS to Report First Quarter Earnings on May 8, 2026

    FIS® (NYSE:FIS), a global leader in financial services technology, will announce first quarter 2026 financial results on Friday, May 8th, prior to market open. The company will sponsor a live webcast of its earnings conference call with the investment community beginning at 8:30 a.m. (EDT) the same day. To access the webcast, go to the Investor Relations section of FIS' homepage, www.fisglobal.com. A replay will be available after the conclusion of the live webcast. About FIS FIS is a financial technology company providing solutions to financial institutions, businesses, and developers. We unlock financial technology to the world across the money lifecycle underpinning the world's fina

    4/23/26 4:30:00 PM ET
    $FIS
    Real Estate

    BRAEMAR HOTELS & RESORTS DECLARES MONTHLY PREFERRED DIVIDENDS FOR APRIL 2026

    DALLAS, April 23, 2026 /PRNewswire/ -- Braemar Hotels & Resorts Inc. (NYSE:BHR) ("Braemar" or the "Company") today announced that its Board of Directors (the "Board") declared, and the Company set aside a partial cash dividend for the Company's 5.5% Series B Cumulative Convertible Preferred Stock equal to: $0.1146 per diluted share, which will be paid on July 15, 2026 to stockholders of record as of June 30, 2026. This amount represents the monthly portion, or one-third, of the full quarterly dividend, which is being set aside each month but will be paid on a quarterly basis. The Board declared and the Company set aside a partial cash dividend for the Company's 8.25% Series D Cumulative Pref

    4/23/26 4:25:00 PM ET
    $BHR
    Real Estate Investment Trusts
    Real Estate

    $AFIB
    $AHG
    $APM
    $APTO
    Leadership Updates

    Live Leadership Updates

    View All

    Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

    Mr. Staab has over 25 years of financial and executive experience across the healthcare industry CHAPEL HILL, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (NASDAQ:TENX) ("Tenax" or "Tenax Therapeutics" or the "Company"), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, announced today the appointment of Thomas R. Staab, II as Chief Financial Officer (CFO), effective May 11, 2026. Mr. Staab brings over 25 years of leadership experience across management and corporate finance roles in the healthcare industry. He will replace Thomas McGauley, who has served as interim CFO since December 2024. "Tom br

    4/22/26 7:00:00 AM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Butterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer – POCUS

    Prominent POCUS thought leader joins to advance clinical strategy and further Butterfly's mission to democratize ultrasound worldwide. Butterfly Network (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Arun Nagdev, MD as Chief Medical Officer – Point-of-Care Ultrasound (POCUS). In this role, Dr. Nagdev will lead the global medical strategy for the Company's core POCUS business, advancing clinical product validation, strengthening customer engagement, and supporting regulatory and clinical development efforts. Dr. Nagdev brings more than 20 years of experience advancing POCUS adoption, educ

    4/21/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Lumen Appoints Jim Ortbals Senior Vice President of Global Partner Solutions

    New senior leader to strengthen channel partner execution, simplify partner motions, and scale outcomes for enterprise customers Lumen Technologies (NYSE:LUMN) today announced that Jim Ortbals will join the company as Senior Vice President of Global Partner Solutions (GPS). Ortbals will lead Lumen's channel partner strategy and execution, with responsibility for strengthening how the company engages, enables, and scales outcomes through this critical part of its commercial approach. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413468127/en/Lumen Senior Vice President of Global Partner Solutions Jim Ortbals "As we transfor

    4/13/26 12:05:00 PM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    $AFIB
    $AHG
    $APM
    $APTO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Acutus Medical Inc.

    SC 13D/A - Acutus Medical, Inc. (0001522860) (Subject)

    12/16/24 9:52:56 PM ET
    $AFIB
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 4:50:19 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care